BrainsWay’s valuation has jumped 20-fold as its brain disorder treatment business takes off...

BrainsWay, an Israeli medical device maker, posted record quarterly revenue of $17 million. The company raised its full-year outlook following a 141% surge in adjusted EBITDA.

Its valuation has increased 20-fold as the brain disorder treatment business takes off.